GlassScriptPhysician profile
Robyn L Ward
NPI 1033401252
$22,375.42
in general payments reported to CMS, 2019-2025
35 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,736 · 2022: $11K · 2023: $4,703 · 2024: $3,645 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,364 · Travel and Lodging: $4,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,363.69 |
| Travel and Lodging | $4,358.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $8,983.09 | 2021-2024 | Optimizer, Optimizer |
| Atricure, INC. | $3,592.62 | 2022-2024 | |
| Medtronic, INC. | $2,364.80 | 2021-2025 | Linq II, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $2,240.09 | 2023 | Watchman Access System, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $1,406.44 | 2021-2025 | Gallant, Aveir, Cardiomems |
| Novartis Pharmaceuticals Corporation | $573.33 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $302.65 | 2021-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $272.43 | 2021-2023 | Xarelto |
| Amgen INC. | $246.15 | 2021-2024 | Repatha, Otezla |
| Pfizer INC. | $228.48 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $205.76 | 2021-2023 | Verquvo |
| Biosense Webster, INC. | $197.17 | 2021 | |
| Novo Nordisk INC | $183.99 | 2021-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $170.49 | 2022-2023 | Camzyos |
| Zoll Respicardia, INC. | $158.87 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $153.85 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $144.57 | 2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $140.02 | 2021-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.28 | 2021-2023 | Jardiance |
| Heartflow, INC. | $107.19 | 2022 | |
| Abbvie INC. | $98.42 | 2022-2025 | |
| Amarin Pharma, INC. | $93.35 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.98 | 2021-2022 | |
| Angiodynamics, INC. | $46.90 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Avanir Pharmaceuticals, INC. | $44.00 | 2022 | |
| Sanofi-Aventis U.S. LLC | $35.11 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.43 | 2021 | |
| Scpharmaceuticals INC. | $32.09 | 2023 | |
| Acadia Pharmaceuticals INC | $21.93 | 2025 | Daybue |
| Eisai INC. | $21.72 | 2021 | |
| Horizon Therapeutics Plc | $21.39 | 2023 | Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $16.96 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.88 | 2022 | |
| United Therapeutics Corporation | $14.73 | 2021 | |
| G Medical Diagnostic Services, INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.